BTG has a portfolio of Interventional Medicine (IM) products that advance the treatment of liver tumours, emphysema, severe blood clots and varicose veins, and a Specialty Pharmaceuticals business focused on niche antidote therapies.
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
BTG has a portfolio of Interventional Medicine (IM) products that advance the treatment of liver tumours, emphysema, severe blood clots and varicose veins, and a Specialty Pharmaceuticals business focused on niche antidote therapies.
